High dose therapy and autologous stem cell transplantation in follicular non-Hodgkin's lymphoma

Leukemia and Lymphoma

Volumn 28, Issue 3-4, 1998, Pages 219-230

  Freedman, Arnold S ^a   Gribben, John G ^a   Nadler, Lee M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bone marrow transplantation; Follicular lymphoma; NHL; Stern cell transplantation

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER REGRESSION; DRUG MEGADOSE; FOLLICULAR LYMPHOMA; MINIMAL RESIDUAL DISEASE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION;

EID: 0031928944     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809092678     Document Type: Review

References (38)

1. Horning, S. J. and Rosenberg, S. A. (1984). The natural history of initially untreated low-grade non-Hodgkin's lymphoma. N. Engl. J. Med., 311, 1471.
2. Gallagher, C. J., Gregory, W. M., Jones, A. E., Stansfeld, A. G., Richards, M. A., Dhaliwal, H. S., Malpas, J. S. and Lister, T. A. (1986). Follicular lymphoma: Prognostic factors for response and survival. J. Clin. Oncol., 4, 1470.
3. Johnson, P., Rohatiner, A., Whelan, J., Price, C., Love, S., Lim, J., Mattews, J., Norton, A., Amess, J. and Lister, T. (1995). Patterns of survival in patients with recurrent follicualr lymphoma: a 20 year study froma single center. J Clin Oncol, 13, 140.
4. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J., Harousseau, J., Coiffier, B., Biron, P., Mandelli, F. and Chauvin, F. (1995). Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Eng J Med, 333, 1540.
5. Young, R. C., Longo, D. L., Glatstein, E., Ihde, D. C., Jaffe, E. S. and DeVita, V. T. (1988). The treatment of indolent lymphomas: Watchful waiting V aggressive combined modality treament. Sem. Hematol., 25, 11.
6. Schouten, H. C., Bierman, P. J., Vaughan, W. P., Kessinger, A., Vose, J. M., Weisenburger, D. D. and Armitage, J. O. (1989). Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation. Blood, 74, 2579.
7. Freedman, A. S., Ritz, J., Neuberg, D., Anderson, K. C., Rabinowe, S. N., Mauch, P., Takvorian, T., Soiffer, R., Blake, K., Yeap, B., Coral, F., Helfin, L. and Nadler, L. M. (1991). Autologous bone marrow transplantation in 69 patients with a history of low grade B-cell non-Hodgkin's lymphoma. Blood, 77, 2524.
8. Vose, J., Bierman, P. and Armitage, J. (1991). High dose chemotherapy with stem cell rescue for the treatment of follicular low grade non-Hodgkin's lymphoma. Autologous Bone Marrow Transplantation. Proceedings of the Fifth International Symposium, V, 479.
9. Rohatiner, A., Johnson, P., Price, C., Arnott, S. J., Amess, J., Norton, A., Dorey, E., Adams, K., Whelan, J., Matthews, J., MacCallum, P., Oza, A. and Lister, T. (1994). Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. J Clin Oncol, 12, 1177.
10. Colombat, P., Donadio, D., Fouillard, L., Milpied, N., Tilly, H., Pico, J., Abrgrall, J., Coiffier, B., Herbrecht, R. and Philip, T. (1994). Value of autologous bone marrow transplantation in follicular lymphoma: A France Autogreffe retrospective study of 42 patients. Bone Marrow Transplant, 13, 157.
11. Haas, R, Murea, S., Moos, M., Hohaus, S., Goldschmidt, H. and Hunstein, W. (1996). High-dose therapy with peripheral blood stem cell transplantation in low-grade non-Hodgkin's lymphomas. Blood, 88, 120.
12. Haas, R., Moos, M., Karcher, A., Mohle, R., Witt, B., Goldschmidt, H., Fruhauf, S., Flentje, M., Wannenmacher, M. and Hunstein, W. (1994). Sequential high dose therapy with peripheral blood progenitor cell support in low grade non-Hodgkin's lymphoma. J Clin Oncol, 12, 1685.
13. Williams, C., Goldstone, A., Pearce, R., Philip, T., Hartmann, O., Colombat, P., Santini, G., Foulard, L. and Gorin, N. (1996). Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry. J Clin Oncol, 14, 2454.
14. Bastion, Y., Brice, P., Haioun, C., Sonet, A., Salles, G., Marolleau, J., Espinouse, D., Reyes, F., Gisselbrecht, C. and Coiffier, B. (1995). Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood, 86, 3257.
15. Bierman, P., Vose, J., Anderson, J., Bishop, M., Kessinger, A. and Armitage, J. (1997). High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. J Clin Oncol, 15, 445.
16. Acker, B., Hoppe, R. T., Colby, T. V., Cox, R. S., Kaplan, H. S. and Rosenberg, S. A. (1983). Histologic Conversion in the non-Hodgkin's lymphomas. J. Clin. Oncol., 1, 11.
17. Gribben, J. G., Freedman, A. S., Neuberg, D., Roy, D. C., Blake, K. W., Woo, S. D., Grossbard, M. L., Rabinowe, S. N., Coral, F., Freeman, G. J., et al. (1991). Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med, 325, 1525.
18. Berinstein, N. L., Jamal, H. H., Kuzniar, B., Klock, R. J. and Reis, M. D. (1993). Sensitive and reproducible detection of occult disease in patients with follicular lymphoma by PCR amplification of t(14; 18) both pre- and post-treatment. Leukemia, 7, 113.
19. Hickish, T. F., Purvies, H., Mansi, J., Soukop, M. and Cunningham, D. (1991). Molecular monitoring of low grade non-Hodgkin's lymphoma by gene amplification. Br J Cancer, 64, 1161.
20. Lambrechts, A. C., Hupkes, P. E., Dorssers, L. C. J. and van't Veer, M. B. (1994). Clinical significance of translocation t(14;18) positive cells in the circulation of patients with stage III or IV follicular non-Hodgkin's lymphoma during first remission. J Clin Oncol, 12, 1541.
21. Brenner, M., Rill, D., Moen, R., Krance, R., Mirro, J., Anderson, W. and Ihle, J. (1993), Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet, 341, 85.
22. Kessinger, A., Armitage, J. O., Smith, D. M., Landmark, J. D., Bierman, P. J. and Weisenburger, D. D. (1989). High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood, 74, 1260.
23. Van Besien, K., Khouri, I., Giralt, S., McCarthy, P., Mehra, R., Andersson, B., Przepiorka, D., Gajewski, J., Bellare, N., Nath, R., Romaguera, J., McLaughlin, P., Korbling, M., Deisseroth, A., Cabanillas, F. and Champlin, R. (1995). Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management. J Clin Oncol, 13, 1096.
24. Soiffer, R., Neuberg, D., Freedman, A., Alyea, E., Fisher, D., Bartlett-Pandite, L., Gribben, J., Schlossman, R., Freeman, A., Anderson, K., Nadler, L. and Ritz, J. (1996). CD6 depleted allogeneic and syngeneic bone marrow transplantation for non-Hodgkin's lymphoma. Blood, 88, 683.
25. Jones, R., Ambinder, R., Piantadosi, S. and Santos, G. (1991). Evidence for a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood, 77, 649.
26. Ratanatharathorn, V., Uberti, J., Karanes, C., Abella, E., Lum, L., Momin, F., Cummings, G. and Sensenbrenner, L. (1994). Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. Blood, 84, 1050.
27. Freedman, A., Gribben, J., Neuberg, D., Mauch, P., Soiffer, R., Anderson, K., Fisher, D., Schlossman, R., Kroon, M., Ritz, J. and Nadler, L. Long term prolongation of disease free and overall survival following autologous bone marrow transplantation in patients with advanced relapsed follicular lymphoma. Proc Am Soc Clin Oncol, in press.
28. Thomas, E. D. and Clift, R. A. (1989). Indications for marrow transplantation in chronic myelogenous leukemia. Blood, 73, 861.
29. Freedman, A., Gribben, J., Neuberg, D., Mauch, P., Soiffer, R., Anderson, K., Pandite, L., Robertson, M., Kroon, M., Ritz, J. and Nadler, L. (1996). High dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood, 88, 2780.
30. Gribben, J., Freedman, A., Woo, S., Blake, K., Shu, R. G. F., Longtine, J., Pinkus, G. and Nadler, L. (1991). All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood, 78, 3275.
31. Tarella, C., Corradini, P., Caracciolo, D., Astolfi, M., Castellino, C. and Gavarotti, P. (1996). High dose chemotherapy as unfront treatment in 35 patients with indolent lymphoma induces a high rate of durable clinical and molecular remission. Blood, 88, 121.
32. Hsu, F., Benike, C., Fagnoni, F., Liles, T., Czerwinski, D., Taidi, B., Engleman, E. and Levy, R. (1996). Vaccination of patients with B-cell lymphoma using autologous antigen pulsed dendritic cells. Nature Med, 2, 52.
33. Schultze, J., Cardoso, A., Freeman, G., Seamon, M., Daley, J., Pinkus, G., Gribben, J. and Nadler, L. (1995). Follicular lymphomas can be induced to present alloantigen efficiently: A conceptual model to improve their tumor immunogenicity. Proc Natl Acad Sci USA, 92, 8200.
34. Grossbard, M., Press, O., Appelbaum, F., Bernstein, I. and Nadler, L. (1992). Monoclonal antibody-based therapies of leukemia and lymphoma. Blood, 80, 863.
35. Press, O., Eary, J., Appelbaum, F., Martin, P., Badger, C., Nelp, W., Glenn, S., Butchko, G., Fisher, D., Porter, B., Matthews, D., Fisher, L. and Bernstein, I. (1993). Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med,329, 1219.
36. Kaminski, M., Zasadny, K., Francis, I., Milik, A., Ross, C., Moon, S., Crawford, S., Burgess, J., Petry, N., Butchko, G., Glenn, S. and Wahl, R. (1993). Radioimmunotherapy of B-cell lymphoma with Anti-B1 (Anti-CD20) antibody. N Engl J Med, 329, 459.
37. Press, O., Eary, J., Applebaum, F., Martin, P., Nelp, W., Glenn, S., Fisher, D., Porter, B., Matthews, D., Gooley, T. and Bernstein, I. (1995). Phase II trial of 131-B1 (anti-Cd20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas. Lancet, 346, 336.
38. Kaminski, M., Zasadny, K., Francis, I., Fenner, M., Ross, C., Milik, A., Estes, J., Tuck, M., Regan, D., Fisher, S., Glenn, S. and Wahl, R. (1996). Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma. J Clin Oncol, 14, 1974.